Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions (Tables)

v3.21.2
Composition of Certain Financial Statement Captions (Tables)
6 Months Ended
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands) June 30,
2021
December 31,
2020
Accounts receivable, net:
Accounts receivable $ 268,327  $ 288,369 
Less: allowance for credit losses (2,471) (2,055)
$ 265,856  $ 286,314 
Inventories, net:
Consumable supplies $ 90,838  $ 86,779 
Finished products 38,870  36,831 
Work in-process 3,449  5,268 
Raw materials 6,409  5,784 
Less: inventory reserve (4,844) (2,321)
$ 134,722  $ 132,341 
Other current assets and prepaid expenses:
Taxes recoverable $ 9,291  $ 13,440 
Prepaid expenses 14,593  7,259 
Prepaid insurance 7,374  3,803 
Other receivables 492  2,502 
Other 15,877  5,309 
$ 47,627  $ 32,313 
Intangible assets, net:
Customer relationships $ 447,484  $ 448,751 
Technologies 290,582  296,623 
Trade names 49,806  49,820 
Covenants not to compete 16,328  16,334 
Licenses 5,766  5,766 
Product registrations 7,803  8,025 
Other 6,351  6,513 
Less: accumulated amortization (378,605) (356,830)
$ 445,515  $ 475,002 
Accrued expenses:
Inventory received but not invoiced $ 33,478  $ 72,160 
Commitments and contingencies 23,161  15,454 
Employee benefits 40,899  43,300 
Contract liabilities 8,400  15,783 
Clinical trials 6,116  7,112 
Contingent consideration 487  1,188 
Finance leases short-term 2,084  2,453 
Professional fees 3,347  4,985 
Other 69,200  78,434 
$ 187,172  $ 240,869 
(In thousands) June 30,
2021
December 31,
2020
Other long-term liabilities:
Contingent consideration $ 2,987  $ 4,507 
Mortgages and other debts payable 3,970  3,837 
Finance leases long-term 2,559  2,805 
Contract liabilities 552  595 
Other 14,798  25,328 
$ 24,866  $ 37,072 
Changes in Goodwill
The following table summarizes the changes in Goodwill by reporting unit during the six months ended June 30, 2021.
2021
(In thousands) Gross goodwill at January 1 Cumulative impairment at January 1 Goodwill impairment Foreign exchange and other Balance at June 30
Pharmaceuticals
CURNA $ 4,827  $ (4,827) $ —  $ —  $ — 
Rayaldee 93,418  —  —  (2,875) 90,543 
FineTech 11,698  (11,698) —  —  — 
OPKO Biologics 139,784  —  —  —  139,784 
OPKO Chile 4,505  —  —  (113) 4,392 
OPKO Health Europe 8,086  —  —  (254) 7,832 
OPKO Mexico 100  (100) —  —  — 
Transition Therapeutics 3,421  (3,421) —  —  — 
Diagnostics
BioReference 434,809  —  —  —  434,809 
OPKO Diagnostics 17,977  (17,977) —  —  — 
$ 718,625  $ (38,023) $ —  $ (3,242) $ 677,360